Overview

Preventing Tolerance to Oxymetazoline in Allergic Rhinitis

Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The investigators wish to evaluate the effects of decongestants like oxymetazoline and the lessening of this effect with time called 'tolerance'. The investigators will demonstrate a reversal of this tolerance with nasal steroids i.e. the investigators will show that nasal steroids protect against tolerance. This will tell us more on how the investigators can make this treatment effective and safe for patients suffering with allergic rhinitis.
Phase:
Phase 4
Details
Lead Sponsor:
Brian J Lipworth
Treatments:
Fluticasone
Oxymetazoline
Phenylephrine
Xhance